Subacute cutaneous lupus erythematosus associated with leflunomide [8]

Clinical and Experimental Dermatology

Volumn 29, Issue 3, 2004, Pages 319-320

  Kerr, O A ^a   Murray, C S ^a   Tidman, M J ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CALCITRIOL; CORTICOSTEROID; DICLOFENAC; HISTONE ANTIBODY; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; LEFLUNOMIDE; PANTOPRAZOLE; RO ANTIBODY;

ADULT; BIOCHEMISTRY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG POTENCY; HEMATOLOGY; HISTOLOGY; HUMAN; LETTER; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; DRUG ERUPTIONS; HUMANS; ISOXAZOLES; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE; MIDDLE AGED;

EID: 2442669156     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01527.x     Document Type: Letter

References (5)

1. Gubinelli E, Cocuroccia B, Girolomoni G. Subacute cutaneous lupus erythematosus induced by nifedipine. J Cutan Med Surg 2003; February 10.
2. Burlingame RW. The clinical utility of antihistone antibodies. Clin Laboratory Med 1997; 17: 367-9.
3. Ross S, Dywer A, Ormerod D et al. Subacute cutaneous lupus erythematosus associated with phenytoin. Clin Exp Derm 2002; 27: 474-6.
4. Remer CF, Weisman MH, Wallace DJ. The benefits of leflunomide in systemic lupus erythematosus: a pilot observational study. Lupus 2001; 10: 480-3.
5. Pantoja L, Gonzalez-Lopez MA, Bouso M et al. Subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis. Scand J Rheumatol 2002; 31: 377-9.